MENU

FATE Fate Therapeutics Forecast, Technical & Fundamental Analysis

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

FATE is expected to report earnings to rise 10.20% to -27 cents per share on October 29

Fate Therapeutics FATE Stock Earnings Reports
Q3'26
Est.
$-0.28
Q2'26
Beat
by $0.02
Q1'26
Beat
by $0.02
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 811.83K shares outstanding, the current market capitalization sits at 279.18M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWDDX16.670.28
+1.71%
American Funds Dvlpg Wld Gr&Inc 529-F-2
THISX98.201.24
+1.28%
T. Rowe Price Health Sciences I
ALMRX30.840.34
+1.11%
Alger Mid Cap Growth Institutional I
PSIFX53.720.23
+0.43%
PGIM Quant Solutions Large-Cap Index Z
HAVGX26.890.10
+0.37%
Haverford Quality Growth Stock

FATE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with NKTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-4.90%
NKTX - FATE
45%
Loosely correlated
+7.69%
VCYT - FATE
44%
Loosely correlated
+1.24%
PTN - FATE
41%
Loosely correlated
-7.01%
REPL - FATE
39%
Loosely correlated
+5.12%
DNA - FATE
38%
Loosely correlated
+6.32%
More
Fate Therapeutics (FATE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com